| Primary |
| Hypertension |
47.1% |
| Pain Management |
9.4% |
| Essential Hypertension |
3.7% |
| Pain |
3.7% |
| Schizophrenia |
3.5% |
| Analgesia |
3.3% |
| Anxiety |
3.3% |
| Diabetes Mellitus |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Attention Deficit/hyperactivity Disorder |
2.4% |
| Depression |
2.4% |
| Affective Disorder |
2.2% |
| Cancer Pain |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Maternal Exposure During Pregnancy |
2.0% |
| Drug Dependence |
1.5% |
| Asthma |
1.3% |
| Hypothyroidism |
1.3% |
| Prophylaxis |
1.3% |
| Blood Pressure |
1.1% |
|
| Somnolence |
13.1% |
| Hypertension |
10.0% |
| Death |
6.9% |
| Hypotension |
6.9% |
| Medication Error |
6.2% |
| Blood Pressure Increased |
5.4% |
| Pneumonia |
5.4% |
| Drug Ineffective |
4.6% |
| Overdose |
4.6% |
| Blood Pressure Inadequately Controlled |
3.8% |
| Drug Abuser |
3.8% |
| Product Substitution Issue |
3.8% |
| Respiratory Depression |
3.8% |
| Dizziness |
3.1% |
| Drug Interaction |
3.1% |
| Dyskinesia |
3.1% |
| Malignant Neoplasm Progression |
3.1% |
| Pulmonary Embolism |
3.1% |
| Respiratory Failure |
3.1% |
| Tachycardia |
3.1% |
|
| Secondary |
| Hypertension |
43.8% |
| Drug Use For Unknown Indication |
8.3% |
| Neuralgia |
6.9% |
| Blood Pressure |
4.5% |
| Anxiety |
4.0% |
| Coronary Artery Disease |
3.8% |
| Affective Disorder |
3.6% |
| Tourette's Disorder |
3.3% |
| Diabetes Mellitus |
2.6% |
| Pain |
2.4% |
| Depression |
2.1% |
| Foetal Exposure During Pregnancy |
1.9% |
| Multiple Sclerosis |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Asthma |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Attention Deficit/hyperactivity Disorder |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| General Anaesthesia |
1.4% |
| Nerve Block |
1.4% |
|
| Weight Increased |
13.8% |
| Drug Ineffective |
10.0% |
| Somnolence |
7.5% |
| Urticaria |
7.5% |
| Vomiting |
7.5% |
| Blood Potassium Increased |
5.0% |
| Blood Pressure Increased |
5.0% |
| Hypertension |
5.0% |
| Overdose |
5.0% |
| Blood Pressure Fluctuation |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Drug Interaction |
3.8% |
| Fall |
3.8% |
| Hypotension |
3.8% |
| Abdominal Discomfort |
2.5% |
| Application Site Erythema |
2.5% |
| Cardiac Failure Congestive |
2.5% |
| Cough |
2.5% |
| Drug Toxicity |
2.5% |
| Dyspepsia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.0% |
| Hypertension |
17.9% |
| Drug Use For Unknown Indication |
10.0% |
| Pain |
8.1% |
| Depression |
3.9% |
| Multiple Myeloma |
3.6% |
| Diabetes Mellitus |
3.4% |
| Nuclear Magnetic Resonance Imaging |
3.3% |
| Anxiety |
2.5% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Blood Cholesterol Increased |
1.5% |
| Blood Pressure |
1.5% |
| Bipolar Disorder |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Ill-defined Disorder |
1.3% |
| Osteoporosis |
1.3% |
| Arthritis |
1.2% |
| Asthma |
1.2% |
| Sleep Disorder |
1.2% |
| Angiogram |
1.2% |
|
| Vomiting |
14.0% |
| Weight Increased |
8.9% |
| Myocardial Infarction |
7.1% |
| Weight Decreased |
7.1% |
| Urinary Tract Infection |
6.7% |
| Pain |
5.4% |
| Renal Failure |
5.4% |
| Type 2 Diabetes Mellitus |
4.7% |
| Drug Ineffective |
4.2% |
| Injury |
3.7% |
| Pruritus |
3.7% |
| Tremor |
3.7% |
| Thrombocytopenia |
3.4% |
| Death |
3.2% |
| Off Label Use |
3.2% |
| Rhabdomyolysis |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Wheezing |
3.2% |
| Pancreatitis |
3.0% |
| Pancreatitis Acute |
3.0% |
|
| Interacting |
| Hypovitaminosis |
50.0% |
| Depressive Symptom |
25.0% |
| Hypertension |
25.0% |
|
|
